Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?
- Kathryn A. Mills
- , Heather Lopez
- , Lulu Sun
- , James C. Cripe
- , Taylor Litz
- , Premal H. Thaker
- , Matthew A. Powell
- , David G. Mutch
- , Katherine C. Fuh
- Division of Gynecologic Oncology
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Department of Obstetrics & Gynecology
- Bursky Center for Human Immunology and Immunotherapy
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Division of Anatomic and Molecular Pathology (AMP)
Research output: Contribution to journal › Article › peer-review
4
Link opens in a new tab
Scopus
citations